$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Plant Phenolics Ferulic Acid and P-Coumaric Acid Inhibit Colorectal Cancer Cell Proliferation through EGFR Down-Regulation

Asian Pacific journal of cancer prevention : APJCP, v.17 no.8, 2016년, pp.4019 - 4023  

Roy, Nabarun (Distributed Information Centre, Kerala Agricultural University) ,  Narayanankutty, Arunaksharan (Amala Cancer Research Centre, University of Calicut) ,  Nazeem, PA (Distributed Information Centre, Kerala Agricultural University) ,  Valsalan, Ravisankar (Distributed Information Centre, Kerala Agricultural University) ,  Babu, TD (Amala Cancer Research Centre, University of Calicut) ,  Mathew, Deepu (Distributed Information Centre, Kerala Agricultural University)

Abstract AI-Helper 아이콘AI-Helper

Background: Colorectal cancer (CRC) or bowel cancer is one of the most important cancer diseases, needing serious attention. The cell surface receptor gene human epidermal growth factor receptor (EGFR) may have an important role in provoking CRC. In this pharmaceutical era, it is always attempted to...

주제어

참고문헌 (39)

  1. Arnold M, Sierra MS, Laversanne M, et al (2016). Global patterns and trends in colorectal cancer incidence and mortality. Gut. 

  2. Bergstrom CA (2005). In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. Basic Clin Pharmacol Toxicol, 96, 156-61. 

  3. Berridge MV, Herst PM, Tan AS (2005). Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev, 11, 127-52. 

  4. Branden G, Sjogren T, Schnecke V, et al (2014). Structure-based ligand design to overcome CYP inhibition in drug discovery projects. Drug Discov Today, 19, 905-11. 

  5. Deller MC, Rupp B (2015). Models of protein-ligand crystal structures: trust, but verify. J Comput Aided Mol Des, 29, 817-36. 

  6. Doak BC, Zheng J, Dobritzsch D, et al (2016). How beyond rule of 5 drugs and clinical candidates bind to their targets. J Med Chem, 59, 2312-27. 

  7. Du X, Li Y, Xia YL, et al (2016). Insights into protein-ligand interactions: mechanisms, models, and methods. Int J Mol Sci, 17, 144. 

  8. El-Seedi HR, El-Said AM, Khalifa SA, et al (2012). Biosynthesis, natural sources, dietary intake, pharmacokinetic properties, and biological activities of hydroxycinnamic acids. J Agric Food Chem, 60, 10877-95. 

  9. Favoriti P, Carbone G, Greco M, et al (2016). Worldwide burden of colorectal cancer: a review. Updates Surg, 68, 7-11. 

  10. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. 

  11. Hammond WA, Swaika A, Mody K (2016). Pharmacologic resistance in colorectal cancer: a review. Ther Adv Med Oncol, 8, 57-84. 

  12. Hatok J, Babusikova E, Matakova T, et al (2009). In vitro assays for the evaluation of drug resistance in tumor cells. Clin Exp Med, 9, 1-7. 

  13. Hou T, Li Y, Zhang W, et al (2009). Recent developments of in silico predictions of intestinal absorption and oral bioavailability. Comb Chem High Throughput Screen, 12, 497-506. 

  14. Katya T, Michel B, Aloise M, et al (2009). ADDME-avoiding drug development mistakes early: central nervous system drug discovery perspective. BMC Neurol, 9, 1. 

  15. Kim S, Thiessen PA, Bolton EE, et al (2016). PubChem substance and compound databases. Nucleic Acids Res, 44, 1202-13. 

  16. Koosha S, Alshawsh MA, Looi CY, et al (2016). An association map on the effect of flavonoids on the signaling pathways in colorectal cancer. Int J Med Sci, 13, 374-85. 

  17. Kubista M, Andrade JM, Bengtsson M, et al (2006). The realtime polymerase chain reaction. Mol Aspects Med, 27, 95-125. 

  18. Lipinski CA (2004). Lead and drug like compounds: the rule of-five revolution. Drug Discov Today Technol, 1, 337-41. 

  19. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real time quantitative PCR and the 2 - ${\Delta}{\Delta}$ CT method. Methods, 25, 402-8. 

  20. Mancuso C, Santangelo R (2014). Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol, 65, 185-95. 

  21. Mohan CG, Gandhi T, Garg D, et al (2007). Computer-assisted methods in chemical toxicity prediction. Mini Rev Med Chem, 7, 499-507. 

  22. Moroy G, Martiny VY, Vayer P, et al (2012). Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov Today, 17, 44-55. 

  23. Narayanankutty A, Mukesh RK, Ayoob SK, et al (2016). Virgin coconut oil maintains redox status and improves glycemic conditions in high fructose fed rats. J Food Sci Tech, 53, 895-901. 

  24. Pabla B, Bissonnette M, Konda VJ (2015). Colon cancer and the epidermal growth factor receptor: current treatment paradigms, the importance of diet, and the role of chemoprevention. World J Clin Oncol, 6, 133-41. 

  25. Park JM, Lee HJ, Yoo JH, et al (2015). Overview of gastrointestinal cancer prevention in Asia. Best Pract Res Clin Gastroenterol, 29, 855-67. 

  26. Pei K, Ou J, Huang J, et al (2016). P-coumaric acid and its conjugates: dietary sources, pharmacokinetic properties and biological activities. J Sci Food Agric, 96, 2952-62. 

  27. Pollastri MP (2010). Overview on the Rule of Five. Curr Protoc Pharmacol, 9, 12. 

  28. Pospisil P, Ballmer P, Scapozza L, et al (2003). Tautomerism in computer-aided drug design. J Recept Signal Transduct Res, 23, 361-71. 

  29. Rose PW, Prlic A, Bi C, et al (2015). The RCSB Protein Data Bank: views of structural biology for basic and applied research and education. Nucleic Acids Res, 43, 345-56. 

  30. Stierand K, Rarey M (2010). Drawing the PDB: protein-ligand complexes in two dimensions. ACS Med Chem Lett, 1, 540-5. 

  31. Sumantran VN (2011). Cellular chemosensitivity assays: an overview. Methods Mol Biol, 731, 219-36. 

  32. Tian S, Wang J, Li Y, et al (2015). The application of in silico drug-likeness predictions in pharmaceutical research. Adv Drug Deliv Rev, 86, 2-10. 

  33. Torre LA, Siegel RL, Ward EM, et al (2016). Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev, 25, 16-27. 

  34. Vanommeslaeghe K, MacKerell AD Jr (2015). CHARMM additive and polarizable force fields for biophysics and computer-aided drug design. Biochim Biophys Acta, 1850, 861-71. 

  35. Veber DF, Johnson SR, Cheng HY, et al (2002). Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem, 45, 2615-23. 

  36. Wrafter PF, Connelly TM, Khan J, et al (2016). The 100 most influential manuscripts in colorectal cancer: a bibliometric analysis. Surgeon. 2016. [Epub ahead of print] 

  37. Wu G, Robertson DH, Brooks CL 3rd, et al (2003). Detailed analysis of grid-based molecular docking: a case study of CDOCKER-a CHARMm-based MD docking algorithm. J Comput Chem, 24, 1549-62. 

  38. Yiu AJ, Yiu CY (2016). Biomarkers in colorectal cancer. Anticancer Res, 36, 1093-102. 

  39. Yuriev E, Holien J, Ramsland PA (2015). Improvements, trends, and new ideas in molecular docking: 2012-2013 in review. J Mol Recognit, 28, 581-604. 

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로